AstraZeneca

U.S. AstraZeneca vaccine trial will clear confusion on how well it works: scientist

AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23… Read More

Britain asks regulator to assess Oxford/AstraZeneca COVID-19 vaccine

AstraZeneca expects 4 million doses to be available in Britain by the end of next… Read More

Oxford’s COVID-19 vaccine can be 90% effective, results show

The vaccine developed by Oxford University was 90% effective in preventing COVID-19 when it was… Read More

Oxford Covid-19 vaccine safe for older adults: results

The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in… Read More

Astrazeneca says trials of COVID-19 vaccine resuming

The late-stage trials of the experimental vaccine, one of the most advanced in development, were… Read More

AstraZeneca should know by year-end whether vaccine works if trials restart

AstraZeneca should still know before the end of the year whether its experimental vaccine protects… Read More

AstraZeneca’s COVID-19 vaccine candidate begins late-stage US study

Trial participants will receive either two doses of the experimental vaccine Read More

Here is what you should know about world’s ‘leading’ COVID-19 vaccine candidate

ChAdOx1 nCoV-19, now known as AZD1222, was developed by Oxford University’s Jenner Institute, working with… Read More

Blood cancer drug shows signs of helping COVID-19 patients

Results from the preliminary research involving 19 patients encouraged the British drugmaker to explore the… Read More

Pharma firm eyes over two billion doses of COVID-19 vaccine

The company said it reached an agreement worth $750 million with the CEPI and Gavi… Read More

Tagrisso gets China OK for type of lung cancer

AstraZeneca said it had received marketing authorization from China’s National Medical Products Administration for its… Read More

Diabetes drug shows promise in heart failure

AstraZeneca made strides on Tuesday towards its goal of adding heart failure to the conditions… Read More

AstraZeneca rebuilds cancer drug hopes with new lung data

MADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on… Read More

Pfizer bid for GSK “has some merits”, says Berenberg

LONDON: Could Pfizer acquire GlaxoSmithKline as a "plan B" after failing to land AstraZeneca? It would… Read More